Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody

Nuclear Medicine and Biology

Volumn 24, Issue 1, 1997, Pages 61-64

  Zhang, Meili ^a   Sakahara, Harumi ^a   Yao, Zhengsheng ^a   Saga, Tsuneo ^a   Nakamoto, Yuji ^a   Sato, Noriko ^a   Nakada, Hiroshi ^b   Yamashina, Ikuo ^b   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

avidin chase; biotinylated antibody; intraperitoneal xenografts; radiolabeled streptavidin

Indexed keywords

BIOTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MLS128; STREPTAVIDIN; STREPTAVIDIN I 125; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; PERITONEUM; RADIOIMMUNOTHERAPY; TUMOR XENOGRAFT;

EID: 0030972274     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(96)00162-X     Document Type: Article

References (20)

1. Alon R., Bayer E. A. and Wilchek M. (1990) Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. Biochem. Biophys. Res. Comm. 170, 1236-1241.
2. Crippa F., Bolis G., Seregni E., Gavoni N., Scarfone G., Ferraris C., Buraggi G. L. and Bombardieri E. (1995) Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18; clinical results in patients with minimal residual disease of ovarian cancer. Eur. J. Cancer 31A, 686-690.
3. 90Y-ZCE025 monoclonal antibody; toxicity and tumor phenotype studies. Cancer Res. (Suppl.) 50, 989s-992s.
4. Chatal J. F., Saccavini J. C., Gestin J. F., Thedrez P., Curtet C., Kremer M., Guerreau D., Nolibe D., Fumoleau P. and Guillard C. (1989) Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res. 49, 3087-3094.
5. Goodwin D. A. (1995) Tumor pretargeting: almost the bottom line. J. Nucl. Med. 36, 876-879.
6. Green N. M. (1975) Avidin. Adv. Protein Chem. 29, 85-133.
7. Hnatowich D. J., Virzi F. and Rusckowski M. (1987) Investigations of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294-1302.
8. Khawli L. A., Alauddin M. M., Miller G. K. and Epstein A. L. (1993) Improved immunotargeting of tumors with biotinylated monoclonal antibodies and radiolabeled streptavidin. Antibody, Immunoconj. Radiopharma. 6, 13-27.
9. Kobayashi H., Sakahara H., Hosono M., Yao Z., Toyama S., Endo K. and Konishi J. (1994) Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J. Nucl. Med. 35, 1677-1684.
10. Muto M. G., Finkler N. J., Kassis A. J., Howes A. E., Anderson L. L., Lau C. C., Zurawski V. R. Jr., Weadock K., Tumeh S. S., Lavin P. and Knapp R. C. (1992) Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125. Gynecol. Oncol. 45, 265-272.
11. Nakada H., Inoue M., Numata Y., Tanaka N., Funakoshi I., Fukui S., Mellors A. and Yamashina I. (1993) Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS128). Proc. Natl. Acad. Sci. USA 90, 2495-2499.
12. Nakada H., Numata Y., Inoue M., Tanaka N., Kitagawa H., Funakoshi I., Fukui S. and Yamashina I. (1991) Elucidation of an essential structure recognized by an anti-GalNAc α-Ser(Thr) monoclonal antibody (MLS128). J. Biol. Chem. 266, 12402-12405.
13. Paganelli G., Pervez S., Siccardi A. G., Rowlinson G., Deleide G., Chiolerio F., Malcovati M., Scassellati G. A. and Epenetos A. A. (1990) Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer 45, 1184-1189.
14. Pearson J. W., Sivam G., Manger R., Wiltrout R. H., Morgan A. C. Jr. and Longo D. L. (1989) Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice. Cancer Res. 49, 4990-4995.
15. Rowlinson G., Snook D., Busza A. and Epenetos A. A. (1987) Antibody-guided localization of intraperitoneal tumors following intraperitoneal or intravenous antibody administration. Cancer Res. 47, 6528-6531.
16. Saga T., Weinstein J. N., Jeong J. M., Heya T., Lee J. T., Le N., Paik C. H., Sung C. and Neumann R. D. (1994) Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res. 54, 2160-2165.
17. Sakahara H., Endo K., Koizumi M., Nakashima T., Kunimatsu M., Watanabe Y., Kawamura Y., Nakamura T., Tanaka H., Kotoura Y., Yamamuro T., Hosoi S., Toyama S. and Torizuka K. (1988) Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies. J. Nucl. Med. 29, 235-240.
18. Thedrez P., Saccavini J. C., Nolibe D., Simoen J. P., Guerreau D., Gestin J. F., Kremer M. and Chatal J. F. (1989) Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinomas. Cancer Res. 49, 3081-3086.
19. Yao Z., Sakahara H., Zhang M., Kobayashi H., Nakada H., Yamashina I. and Konishi J. (1995) Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody. Nucl. Med. Biol. 22, 199-203.
20. Yao Z., Zhang M., Kobayashi H., Sakahara H., Nakada H., Yamashina I. and Konishi J. (1995) Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J. Nucl. Med. 36, 837-841.